Blog Post
Efficacy on men was trialled in the US and a report presented to SABCS last year:
There appear to have been studies in Australia, so what are the results that led to men being excluded?
- Ribociclib in combination with everolimus and exemestane in men and postmenopausal women with HR+/HER2- advanced breast cancer following progression on a CDK4/6 inhibitor: Efficacy and updated safety and pharmacokinetic results from phase 1 of the TRINITI-1 study [Abstract #PD5-11; Thursday, December 7, 5:00 - 7:00 PM CST]
There appear to have been studies in Australia, so what are the results that led to men being excluded?
Related Content
1 MIN READ
BCNA’s Online Network will be temporarily unavailable from 7pm AEST, July 1, 2025, until the morning of July 2, 2025.
During this time, you will not be able to access the Online Network.
This...
18 days agoI know I'm not alone in this journey but tonight I'm really feeling quite lonely. Just wondering what other people do when they are feeling this way even when they might be surrounded by supportive fa...
2 years agoHello Girls :) I am in a much better frame of mind today, I apologise profusely for my display of "woe is me" attitude. I cannot promise it wont happen again BUT one can but try to control themselv...
9 years agoSo, Friday myself, my husband, my son & 12 friends flew to Queensland to compete in various Gold Coast Marathon events. Myself in the 5.7km, so stoked to tell you that I ran the entire 5.7km in 44...
9 years agoYou may have seen an email pop into your inbox from BCNA about a webinar tonight on psychological impact of BC. I'm hoping that it will be good as, having heard Dr Tottman speak at the conference las...
6 years ago